Joris Wilms serves as Executive at Y-mAbs Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joris Wilms has executed 5 insider transactions totaling $73.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 16, 2025 involved selling 39,301 shares valued at $0.
Joris Wilms currently holds 30,600 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joris Wilms has been a net seller of YMAB stock. They have purchased $0 and sold $73.5K worth of shares.
Joris Wilms's most recent insider trade was on Sep 16, 2025, when they sold 39,301 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.60 |
| Discretionary |
| Aug 26, 2024 | YMAB | $73.5K | Sale | 5,000 | $14.69 | Discretionary |
| Jan 18, 2024 | YMAB | $0 | Award | 17,800 | $N/A | Discretionary |
| Jan 17, 2023 | YMAB | $0 | Award | 17,800 | $N/A | Discretionary |